NASDAQ:BGNE - BeiGene, Ltd.
$137.81
 $-1.04
-0.75%
1:30PM EDT
2019-02-22
BeiGene, Ltd. is a clinical-stage biopharmaceutical company. The Company is focused in the discovery and development of molecularly targeted and immuno-oncology drugs for the treatment of cancer. The Company had used its cancer biology platform to develop four clinical-stage drug candidates, such as BGB-3111, BGB-A317, BGB-290 and BGB-283, as of December 31, 2016. BGB-3111, BGB-290 and BGB-283 are its molecularly targeted agents and is its immuno-oncology agent. BGB-3111 is a potent and highly selective small molecule inhibitor of Bruton's tyrosine kinase (BTK). BGB-283 is a molecule inhibitor of both the monomer and dimer forms of the RAF kinase. BGB-290 is a molecularly targeted, orally available, potent and highly selective inhibitor of the poly ADP ribose polymerase (PARP) family members. BGB-A317 is an investigational humanized monoclonal antibody against the immune checkpoint receptor, PD-1. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BGNE     avg for
industry  
  avg for
sector  
42 stocks weight:  102. 55   0. 00   0. 00  
42 stocks rank:  1. 77 K 1. 75 K 1. 04 K
# analyst opinions:  9. 00   14. 71   14. 20  
mean recommendation:  1. 60   1. 96   1. 94  

quick ratio:  11. 03   5. 11   1. 74  
current ratio:  11. 57   5. 42   2. 10  

target price low:  160. 30   90. 14   118. 49  
target price avg:  194. 26   116. 45   142. 48  
target price high:  214. 00   142. 04   163. 43  
1-yr high:  216. 77   124. 43   143. 35  
last close:  139. 01   102. 79   129. 91  
50-day avg:  133. 97   98. 71   122. 84  
200-day avg:  154. 42   100. 04   123. 36  
1-yr low:  107. 01   78. 37   100. 37  
volume:  279. 45 K 2. 53 M 4. 41 M
50-day avg volume:  432. 34 K 3. 20 M 4. 84 M
200-day avg volume:  403. 66 K 3. 17 M 4. 23 M

1-day return:  0. 06 % -0. 26 % -0. 20 %
this week return:  5. 14 % -1. 09 % -0. 43 %
12-wk return:  -9. 33 % 0. 61 % -1. 00 %
52-wk return:  -0. 72 % -1. 83 % 15. 65 %

enterprise value (EV):  5. 84 B 55. 56 B 106. 65 B
market cap:  8. 27 B 48. 78 B 97. 32 B
EBITDA:  -503. 37 M 4. 80 B 7. 16 B
enterprise multiple (EV/EBITDA):  -11. 60   9. 43   16. 93  
enterprise/revenue (EV/R):  33. 55   30. 55   23. 98  
total revenue:  174. 03 M 11. 22 B 40. 12 B
total debt:  195. 97 M 13. 64 B 16. 70 B
debt/equity:  9. 88   41. 58   80. 88  
net income (common):  -507. 77 M 2. 37 B 3. 60 B

shares outstanding:  59. 53 M 603. 08 M 1. 22 B
shares:  30. 81 M 602. 41 M 1. 14 B
shares short:  3. 46 M 10. 60 M 11. 84 M
shares short prior month:  3. 25 M 11. 98 M 11. 79 M
short ratio:  6. 47   4. 85   3. 17  
total cash/share:  35. 74   12. 01   10. 06  
total cash:  2. 03 B 7. 38 B 7. 05 B
free cash flow:  -176. 64 M 175. 43 M 2. 45 B
operating cash flow:  -260. 07 M 276. 49 M 3. 08 B

book value:  34. 63   15. 02   29. 01  
price/book:  4. 01   -1. 21   -3. 11  
gross profits:  -19. 30 M 8. 46 B 19. 33 B
operating margins:  -294. 46 % -448. 53 % -625. 18 %
EBITDA margins:  -289. 24 % 13. 96 % 22. 59 %
profit margins:  -291. 77 % 6. 99 % 10. 07 %
gross margins:  -207. 66 % 48. 33 % 54. 27 %

1-yr max volatility:  13. 78 % --- ---
1-yr mean volatility:  0. 07 % 0. 01 % 0. 07 %

1-yr EPS:  -9. 81   3. 09   4. 12  
forward EPS:  -11. 59   4. 79   7. 22  
P/E:  -14. 17   16. 12   29. 23  
forward P/E:  -11. 41   -20. 07   2. 62  
PE/G:  0. 19   1. 22   5. 95  
growth:  -75. 40 % 751. 62 % 114. 63 %
earnings high:  -1. 58   1. 34   1. 69  
earnings avg:  -2. 73   0. 98   1. 55  
earnings low:  -3. 25   0. 71   1. 43  
revenue high:  118. 06 M 2. 85 B 11. 42 B
revenue avg:  66. 48 M 2. 74 B 11. 10 B
revenue low:  40. 37 M 2. 65 B 10. 88 B
return on assets:  -18. 53 % -3. 49 % 3. 81 %
return on equity:  -37. 06 % 105. 25 % 27. 50 %
revenue growth:  -75. 40 % 713. 56 % 106. 99 %
revenue/share:  3. 35   14. 72   60. 38  

beta (1yr vs S&P500):  0. 86   1. 21   0. 94  
sharpe (1yr):  0. 35   0. 06   1. 00  

held % insiders:  0. 03 % 6. 33 % 3. 17 %
held % institutions:  88. 21 % 79. 54 % 70. 80 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-20 : BGNE
.    + 1.979 =         1.979 :: INITIAL WEIGHT
.   + 293.81 =        295.79 :: inverse volume-to-price addition
.  + 297.596 =       593.386 :: spline projection addition
.  + 936.755 =      1530.141 :: notable performance addition
.   - 126.71 =      1403.431 :: poor performance penalty
.    x 1.017 =      1427.774 :: one-year gains+dividend factor
.    x 6.276 =      8961.405 :: 13 weeks' performance factor
.    x 1.476 =     13224.803 :: industry recommendation factor
.    x 2.914 =     38537.805 :: symbol recommendation factor
.    x 1.902 =     73289.466 :: EV/R factor
.    x 0.998 =      73153.69 :: return on assets factor
.    x 0.996 =      72882.59 :: return on equity factor
.    x 0.992 =     72333.055 :: revenue growth factor
.    x 2.135 =    154435.473 :: current ratio factor
.    x 1.049 =    161949.073 :: quick ratio factor
.    x 1.075 =    174014.976 :: short ratio factor
.     x 2.04 =     355015.98 :: price-to-book factor
.    x 1.112 =    394947.372 :: debt-to-equity factor
.    x 1.016 =    401103.039 :: 5-day avg > 50-day avg
.    x 1.821 =    730329.123 :: P/E weight
.    x 1.519 =   1109247.002 :: PE/G factor
.    x 1.644 =   1824111.949 :: beta factor
.    x 0.348 =     634112.32 :: sharpe factor
.      x 1.4 =    887830.916 :: target low factor
.     x 1.21 =   1074405.348 :: target mean factor
.    x 1.073 =   1153318.032 :: target high factor
.    x 1.006 =   1160356.779 :: industry 12-weeks return
.    x 0.973 =   1128906.076 :: "drift" penalty 4 days ago
.      x 1.0 =   1128634.914 :: overall "drift" factor
.    x 0.862 =    973140.452 :: largest single-day jump factor
.     x 1.01 =    982864.911 :: mean volatility factor
.    x 1.098 =   1078701.689 :: 42-day mean volatility factor
.      x 1.0 =    1078577.31 :: factor hist industry gain for week 07
.   cubeRoot =       102.553 :: reduced for readability
.                    102.553 :: FINAL WEIGHT for NASDAQ:BGNE


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org